1.Application value of tissue dispersion quantitative analysis technique in different stages of SAT
Chuanju ZHANG ; Chunping NING ; Jiawei TIAN ; Bowen ZHAO ; Jiang ZHU ; Jianghong LV ; Haishan XU ; Jinduo SHOU ; Liming YANG ; Ran CHEN
Chinese Journal of Ultrasonography 2017;26(5):419-423
Objective To investigate the application value of the ultrasonic elastic tissue dispersion quantitative analysis technique in different stages of subacute thyroiditis (SAT).Methods One hundred and forty-four SAT lesions detected from 81 patients were enrolled in the patient group.They were further divided into three subgroups,including acute group (group Ⅰ),medium group (group Ⅱ) and recovery group (group Ⅲ).Another 59 healthy volunteers were collected as control group.All the participants accepted conventional ultrasound and elastographic examinations.Eleven parameters were obtained by the tissue dispersion quantitative analysis software.These parameters were compared between groups and among subgroups by ANOVA.The correlation between all the parameters and the course of SAT were analyzed by Spearman and Multiple linear regression methods.Results Between groups and among subgroups,the complexity (COMP) and correlation (CORR) were not statistically different(all P >0.05).Differences of kurtosis (KURT) and angular secon moment (ASM) among the three subgroups were not significant (all P >0.05).Differences between groups and among subgroups were significantly different among the value of all the other seven indexes (all P <0.01).Moreover,they were all correlated with the clinical staging,with the highest coefficient in area ration of low-strain region (% AREA)(r =-0.881).Regression model was constructed and only % AREA was selected into the regression equation.ROC curves were constructed to estimate the clinic value of % AREA in staging patients of SAT,the areas under ROC curves were0.986(group Ⅰ vs group Ⅱ-Ⅲ) and 0.988 (group Ⅰ-Ⅱ vs group Ⅲ[) for %AREA,respectively.Conclusions The tissue dispersion quantitative analysis technique is helpful in estimating the stiffness of thyroid in patients with SAT.
2.Application of BiPAP non-invasive positive pressure ventilation in pre-hospital first aid
Rongjie LI ; Junxiong LIANG ; Bowen LV ; Junqiang MO ; Deming ZHAO
China Modern Doctor 2014;(14):133-135
Objective To investigate the usage of BiPAP noninvasive positive pressure ventilation in pre-hospital first aid and the effect. Methods A total of 108 patients with any of the following diseases, AECOPD,AHF,ARDS and se-vere bronchial asthma were selected and divided into BiPAP treatment group and routine treatment group according to digital randomized method. Each group included 54 patients. Breath, heart rate, blood gas analysis, changes in hemo-dynamic parameters of two groups before and after treatment and curative effecty were analyzed. Results After treat-ment, breath, heart rate, blood gas analysis, hemodynamic parameters of BiPAP treatment group were better con-trolled than that of conventional treatment group (P < 0.05). The total effective rate of BiPAP treatment group was 92.59%, which was significantly higher than that of the conventional treatment group (P< 0.05). Conclusion The ap-plication of BiPAP in pre-hospital emergency treatment can quickly relieve symptoms and increase curative effect. It is worthy of using widely in clinical treatment.
3.Effect of microRNA-150 on proliferation,apoptosis,invasion and metastasis of epithelial ovarian cancer cells
Wenhui LI ; Bowen LV ; Jun QIAN ; Liju SU ; Tongshu YANG ; Jingrong QIAN ; Jie WANG
Practical Oncology Journal 2018;32(3):208-213
Objective The aim of this study was to investigate the expression of microRNA-150(miR-150)in human epi-thelial ovarian cancer cells and its effect on proliferation,apoptosis,invasion and metastasis of human epithelial ovarian cancer cells. Methods The expression level of miR-150 in cells from each treatment group was detected by Real-Time PCR(qRT-PCR);effects of proliferation,apoptosis,invasion and metastasis of epithelial ovarian cancer cells was investigated by MTT,flow cytometry, and transwell assays. Results Compared with normal ovarian epithelial cells(T29),the expression of miR-150 was significantly de-creased in epithelial ovarian cancer cells(A2780 and OVCAR3)(P<0. 01); After transfection miR-150 mimic,the expression of miR-150 in A2780 and OVCAR3 cells was significantly increased(P<0. 01);After 3 d of transfection,the OD values of the miR-150mimicgroup(A2780:1.12±0.03;OVCAR3:1.91±0.03)werelowerthanthatintheblankgroup(A2780:2.35±0.09;OVCAR3:2.63 ±0.07)and the miR-150 NC group(A2780:2.18 ±0.07;OVCAR3:2.43 ±0.11)(P<0.01);The apoptotic rate in the miR-150 mimic group(A2780:16. 10 ± 0. 58% ;OVCAR3:15. 16 ± 1. 30% ) were significantly increased when compared to the blank group(A2780:10. 07 ± 0. 66%;OVCAR3:3. 81 ± 0. 24%) and the miR -150 NC group(A2780:10. 36 ± 1. 08%;OVCAR3:4.89 ±0.07%)(P<0.01);The number of transmembrane cells in the miR-150 mimic group(A2780:38.67 ±2.03;OVCAR3:28. 67 ± 2. 03)was higher than that in the blank group(A2780:76. 30 ± 7. 45;OVCAR3:55. 67 ± 3. 18)and the miR-150 NC group(A2780:74. 33 ± 5. 78;OVCAR3:56. 33 ± 3. 84)(P<0. 01). Conclusion The decreased expression of miR-150 in epi-thelial cancer cells may be one of the mechanisms of proliferation,invasion and metastasis of epithelial ovarian cancer. Up-regulation of miR-150 may inhibit the proliferation of epithelial ovarian cancer cells and promote apoptosis to reduce the abilities of invasion and metastasis in epithelial ovarian cancer cells.
4.Expression of MiR-455-5p in epithelial ovarian cancer and its target gene function
Bowen LV ; Jun QIAN ; Jie WANG ; Jingrong QIAN ; Yingying LU ; Liju SU ; Tongshu YANG ; Wenhui LI
Practical Oncology Journal 2019;33(2):115-121
Objective The aim of this study was to investigate the expression of miR-455-5p in epithelial ovarian cancer and its effect on the development of epithelial ovarian cancer. Methods The miRNA expression data of normal ovarian epithelial tis-sues and epithelial ovarian cancer tissues GSE83693 were downloaded from the GEO database. Differential expression analysis was used to obtain differential expression data of miRNAs in epithelial ovarian cancer. The expression of miR-455 -5p was analyzed whether there is difference expression between normal ovarian epithelium and epithelial ovary cancer tissues; qRT-PCR was used to verify the differential expression prediction results; bio-informatics software was used to analyze the KEGG pathway enrichment and GO gene function annotation of miR-455-5p target genes,and to explore the disorders of dyregulated miR-455-5p in the devel-opment of epithelial ovarian cancer. Results A total of 101 cases of differentially expressed miRNAs were screened,34 cases were up-regulated and 67 cases were down-regulated. Among them,miR-455-5p was down-regulated significantly(P<0. 01),and the different fulds were -2. 9019. The results of qRT-PCR showed that the expression of miR-455-5p in epithelial ovarian cancer cells(SKOV-3,OVCAR-3 and A2780)was significantly lower than that in normal ovarian epithelial cells(IOSE-80),and the dif-ferential expression was statistically significant(P<0. 05). The results of KEGG pathway enrichment analysis showed that miR-455-5p regulated target genes mainly involved in five pathways,including TGF-β signaling pathway,Hippo signaling pathway,ECM-receptor interaction,transcriptional dysregulation pathway in cancer,and chronic granule cellular leukemia,which were associated with tumors. GO functional annotation analysis showed that the target genes regulated by miR-455-5p in the above pathway was mainly involved in protein phosphorylation,promoted cell proliferation and migration,inhibited apoptosis,promoted epithelial-mesenchymal transition,regulated transcription and regulated cell cycle,etc. ,which associated with tumorigenesis. Conclusion The expression of miR-455-5p is down-regulated in epithelial ovarian cancer. The miR-455-5p target genes are involved in the pathogenesis and function of epithelial ovarian cancer,and are associated with the development of epithelial ovarian cancer.